Although survival endpoints did not reach statistical significance, the observed trends favored combination strategies, supporting the biological plausibility of therapeutic synergy through multiple immune activation mechanisms.
← all excerpts
A Comprehensive Review of Immunotherapeutic Modalities in Glioblastoma: Mechanisms, Efficacy, and Safety Considerations <sup>†</sup>.
1
—
—